Home › Pain After Surgery › Texas › Houston
Pain After Surgery clinical trials in Houston, TX
5 studies for Pain After Surgery are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
Recruiting
- University of Texas - MD Anderson, Houston
A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves
RecruitingObservational study
- Baylor College of Medicine, Houston
PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)
RecruitingPhase 3
- HD Research - Memorial Hermann Surgery Center, Houston
Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery
RecruitingPhase 1
- The University of Texas Health Science Center at Houston (UTHSC-H) - McGovern Medical School, Houston
A Longitudinal Study Looking at the Prevalence, Risk Factors & Consequences of Persistent Post-surgical Pain in Children
RecruitingObservational studyHealthy volunteers welcome
- Texas childrens hospital, Houston
Pain After Surgery trials in other cities
- Boston, MA11 studies
- New York City, NY10 studies
- St. Louis, MO8 studies
- Los Angeles, CA6 studies
- Salt Lake City, UT5 studies
- San Diego, CA5 studies
- San Francisco, CA5 studies
- Baltimore, MD5 studies
- Dallas, TX4 studies
- Cleveland, OH4 studies
- Philadelphia, PA4 studies
- Ann Arbor, MI4 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.